Jennifer Buell
Vermögen: 775 975 $ am 31.05.2026
Vermögen: 775 975 $ am 31.05.2026
Dr. Jennifer S.
Buell is a President, Chief Executive Officer & Director at MiNK Therapeutics, Inc., an Independent Director at Protagenic Therapeutics, Inc., a Chief Executive Officer at AgenTus Therapeutics Ltd. and a Chief Executive Officer at AgenTus Therapeutics SA. She is on the Board of Directors at Agenus, Inc., MiNK Therapeutics, Inc. and Protagenic Therapeutics, Inc. She received her graduate degree from Tufts University and a doctorate degree from Tufts University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MINK THERAPEUTICS, INC. 1,16 % | 23.04.2026 | 57.942 ( 1,16 % ) | 706 892 $ | 31.05.2026 |
AGENUS INC. 0,05 % | 24.04.2026 | 19.738 ( 0,05 % ) | 69 083 $ | 31.05.2026 |
| 30.11.2025 | 0 ( -.--% ) | - $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| PROTAGENIC THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 18.07.2020 |
| MINK THERAPEUTICS, INC. | Vorstandsvorsitzender | 01.02.2021 |
| AGENUS INC. | Direktor/Vorstandsmitglied | 11.06.2024 |
AgenTus Therapeutics SA | Vorstandsvorsitzender | - |
AgenTus Therapeutics Ltd. | Vorstandsvorsitzender | - |
| Unternehmen | Position | Ende |
|---|---|---|
| AGENUS INC. | Präsident | 31.12.2021 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Agenus, Inc.
Agenus, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of technologies to treat cancers and infectious diseases | Health Technology |
Tufts University
Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protagenic Therapeutics, Inc.
Protagenic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company that engages in discovery and development of therapeutics to treat stress-related neuropsychiatric & mood disorders | Health Technology |
MiNK Therapeutics, Inc.
MiNK Therapeutics, Inc. BiotechnologyHealth Technology Provides bio pharmaceutical services | Health Technology |
AgenTus Therapeutics Ltd. | |
AgenTus Therapeutics SA |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen